Eton Pharmaceuticals Inc (ETON) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Eton Pharmaceuticals Inc   (NASDAQ: ETON)
 

Eton Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Eton Pharmaceuticals Inc inventory turnover ratio, the Eton Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 3.11 in the second quarter 2026, yet the ratio remained below the average, as ETON's market remain challenging.Average inventory processing period, for the Eton Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 117 days, compare to 165 days, in the Mar 31 2026 quarter.

Within Healthcare sector 121 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 1235.

ETON Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Eton Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ETON Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -57.37 % 6.21 % 1.23 % 769.71 % 1050.44 %
Y / Y Cost of Sales Growth 73.94 % 28.57 % 50 % 250 % 133.33 %
Inventory Turnover Ratio (TTM) 3.11 2.21 2.12 1.96 1.76
ETON's Total Ranking # 1235 # 1235 # 1283 # 986 # 1306
Average inventory processing period 117 165 172 187 208
Seq. Inventory Growth -29.89 % -6.17 % -8.52 % -29.15 % 74.66 %
Seq. Cost of Sales Growth 35.29 % 0 % -35.71 % 100 % 0 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 26
Healthcare Sector # 122
Overall Market # 1235

Inventory Turnover Ratio Statistics
High Average Low
16.3 5.65 0.34
(Mar 31 2023)   (Dec 31 2020)



ETON Company Profile >> Back to ETON Efficiency Comparisons >> Compare ETON Inventory Turnover Ratio to its Competitors

Financial Statements
Eton Pharmaceuticals Inc 's Inventories $ 10 Millions Visit ETON's Balance sheet
Eton Pharmaceuticals Inc 's Cost of Revenues TTM $ 44 Millions Visit ETON's Income Statement
What are ETON's Sales? Visit ETON's Sales by Segment

Other Inventory Turnover Ratios
Eton Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ETON's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ETON's Competitors
Inventory Turnover Ratio for ETON's Suppliers
Inventory Turnover Ratio for ETON's Customers

You may also want to know
ETON's Sales Growth Rates ETON's Pe Price to earnings ratio ETON's Receivables Turnover Ratio ETON's Stock Quote
ETON's Net Income Growth Rates ETON's Ps Price to Sales ratio ETON's Sales per Employee ETON's Asset Turnover Ratio
ETON's Net Margin ETON's Pb Price to Book ratio ETON's Financial Strength Ratios ETON's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions

Date modified: 2026-09-03T11:44:38+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.